Search | IOVS | ARVO Journals

Showing 1 – 20 of 52

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2017

Standardization of retinal thickness and volume on ETDRS grid subdivisions using SD-OCT

Renato Peroni; Rafael Memória; Bruno Nascimento; Lucélia Albieri; Murilo Wendeborn Rodrigues; José Augusto Cardillo; Rodrigo Jorge

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1320. doi:

ARVO Annual Meeting Abstract June 2017

The Influence of Dark and Light Adaptation on Phosphene Thresholds Elicited with DTL Electrodes

renan rocha memória; Santana José Galdino Souza; Rodrigo Jorge; Andre Messias

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5879. doi:

ARVO Annual Meeting Abstract June 2017

Bevacizumab or Triamcinolone for Persistent Diabetic Macular Edema: 24-week preliminary results

Murilo Wendeborn Rodrigues; Andre Messias; Jose Augusto Cardillo; Rubens C Siqueira; Rodrigo Jorge

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):954. doi:

ARVO Annual Meeting Abstract June 2017

Combined Pars Plana Vitrectomy (PPV) and Phacoemulsification (Phaco) versus PPV and Deferred Phaco for Patients with Macular Hole (MH) or Epiretinal Membrane (ERM)

Rodrigo Jorge; Karlos Italo Viana; David Lucena; Marcelo Menegatti Esperandio; Denny Marcos Garcia; Felipe Piacentini Almeida; Andre Messias; Ingrid U Scott

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2805. doi:

ARVO Annual Meeting Abstract September 2016

Intravitreal Autologous Bone Marrow Derived Stem Cells in Dry Age-related Macular Degeneration

Rubens C Siqueira; Carina Costa Cotrim; Andre Messias; Monique Viana de Sousa; Luiza Toscano; Rodrigo Jorge

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3704. doi:

ARVO Annual Meeting Abstract September 2016

Intravitreal Autologous Bone Marrow Derived Stem Cells in Ischemic Maculopathy Results after 12 Months Follow-up

Felipe Placeres Borges; Rubens C Siqueira; Murilo Wendeborn Rodrigues; Amanda Jardim Dos Santos; Andre Messias; Rodrigo Jorge

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3741. doi:

ARVO Annual Meeting Abstract September 2016

Reduced photoreceptor density over Choroid Nevus

Murilo Wendeborn Rodrigues; Jose A Cardillo; Emil Say; Felipe Borges; Rubens C Siqueira; Rodrigo Jorge

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5099. doi:

ARVO Annual Meeting Abstract September 2016

Adaptive optics and its correlation with multimodal imaging and microperimetry in patients with macular capillary loss

Rodrigo Jorge; Felipe Placeres Borges; Murilo Wendeborn Rodrigues; Ingrid U Scott; Rubens C Siqueira

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):6317. doi:

ARVO Annual Meeting Abstract June 2015

Intravitreal Autologous Bone Marrow Derived Cells in Stargardt disease patients: Results after 3 months follow-up

Luiza Toscano; Carina Costa Cotrim; Rodrigo Jorge; Andre Messias; Rubens C Siqueira

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3828. doi:

ARVO Annual Meeting Abstract June 2015

Intravitreal Autologous Bone Marrow Derived Stem Cells in Ischemic Macular Edema - Results after 6 Months Follow-up

Monique Viana de Sousa; Rodrigo Jorge; Andre Messias; Carina Costa Cotrim; Murilo Wendeborn Rodrigues; Rubens C Siqueira

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4718. doi:

ARVO Annual Meeting Abstract June 2015

Intravitreal Autologous Bone-Marrow Stem Cells in nonexudative macular degeneration (dry AMD) patients: Results after 3 Months Follow-up

Carina Costa Cotrim; Rodrigo Jorge; Andre Messias; Monique Viana de Sousa; Luiza Toscano; Rubens C Siqueira

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3783. doi:

ARVO Annual Meeting Abstract June 2015

Quality of life in patients with retinitis pigmentosa undergoing treatment with intravitreal bone marrow-derived stem cells (Reticell -clinical trial)

Rubens C Siqueira; Andre Messias; Katharina Messias; Rafael Arcieri; Milton A Ruiz; Neiglene F Souza; Lia C Martins; Rodrigo Jorge

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3812. doi:

ARVO Annual Meeting Abstract June 2015

PASCAL panretinal photocoagulation (PRP) versus ETDRS PRP associated with intravitreal Ranibizumab (IVR) versus only IVR for proliferative diabetic retinopathy treatment

Rafael de Montier Barroso; Andre Messias; Jose A Cardillo; Rodrigo Jorge; Ophthalmology Department, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1773. doi:

ARVO Annual Meeting Abstract June 2015

Full-field Stimulus Threshold (FST) Changes After Intravitreal Ranibizumab and Single or Multiple Spot Panphotocoagulation in Proliferative Diabetic Retinopathy

Andre Messias; Katharina Messias; Rafael de Montier Barroso; Amanda Marega; Rodrigo Jorge

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1776. doi:

ARVO Annual Meeting Abstract June 2015

Comparative efficacy of two different regimens of povidone-iodine 5% eye drops instillation in reducing conjunctival bacterial flora

Leticia Barroso; Antonio Brunno Nepomuceno; Sarah P. Cazella; Luiza Toscano; Jefferson Ribeiro; Andre Messias; Rodrigo Jorge

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):279. doi:

ARVO Annual Meeting Abstract June 2015

ERG Findings after One Year Intravitreal Ranibizumab and Single or Multiple Spot Panphotocoagulation Treatment for Proliferative Diabetic Retinopathy

Katharina Messias; Rafael de Montier Barroso; Fabiano Sakamoto; Vinicius Monteiro de Castro; Amanda Marega; Rodrigo Jorge; Andre Messias

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):764. doi:

ARVO Annual Meeting Abstract June 2015

Reduced-Dose Indocyanine Green Photodynamic Therapy (iPDT) as an Optimized Treatment for Chronic Central Serous Chorioretinopathy

Jose A Cardillo; Leticia Barroso; Murilo Wendeborn Rodrigues; Rodrigo Jorge; Acacio Lima

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):201. doi:

ARVO Annual Meeting Abstract April 2014

The Sympatholytic Non-selective β-blocker PROPRANOLOL as A Non-invasive Therapeutic Approach for the Treatment of Chronic Central Serous Chorioretinopathy (CSC)

Jose A Cardillo; Murilo Wendeborn Rodrigues; Leticia Fernandes Barroso; Rubens C Siqueira; Rodrigo Jorge

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):6380. doi:

ARVO Annual Meeting Abstract April 2014

Chromatic Full-field Stimulus Threshold (FST) in Proliferative Diabetic Retinopathy

Andre Messias; Katharina Messias; Rafael Saran Arcieri; Fabiano Sakamoto; Vinicius M Castro; Rodrigo Jorge

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):335. doi:

ARVO Annual Meeting Abstract April 2014

Changes in Retinal Function and Structure Following Intravitreal Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Treatment for Diabetic Macular Edema

Monique Viana de Sousa; Antonio Brunno Nepomuceno; Andre Messias; Rodrigo Jorge; Ingrid U Scott

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1100. doi:

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Standardization of retinal thickness and volume on ETDRS grid subdivisions using SD-OCT

The Influence of Dark and Light Adaptation on Phosphene Thresholds Elicited with DTL Electrodes

Bevacizumab or Triamcinolone for Persistent Diabetic Macular Edema: 24-week preliminary results

Combined Pars Plana Vitrectomy (PPV) and Phacoemulsification (Phaco) versus PPV and Deferred Phaco for Patients with Macular Hole (MH) or Epiretinal Membrane (ERM)

Intravitreal Autologous Bone Marrow Derived Stem Cells in Dry Age-related Macular Degeneration

Intravitreal Autologous Bone Marrow Derived Stem Cells in Ischemic Maculopathy Results after 12 Months Follow-up

Reduced photoreceptor density over Choroid Nevus

Adaptive optics and its correlation with multimodal imaging and microperimetry in patients with macular capillary loss

Intravitreal Autologous Bone Marrow Derived Cells in Stargardt disease patients: Results after 3 months follow-up

Intravitreal Autologous Bone Marrow Derived Stem Cells in Ischemic Macular Edema - Results after 6 Months Follow-up

Intravitreal Autologous Bone-Marrow Stem Cells in nonexudative macular degeneration (dry AMD) patients: Results after 3 Months Follow-up

Quality of life in patients with retinitis pigmentosa undergoing treatment with intravitreal bone marrow-derived stem cells (Reticell -clinical trial)

PASCAL panretinal photocoagulation (PRP) versus ETDRS PRP associated with intravitreal Ranibizumab (IVR) versus only IVR for proliferative diabetic retinopathy treatment

Full-field Stimulus Threshold (FST) Changes After Intravitreal Ranibizumab and Single or Multiple Spot Panphotocoagulation in Proliferative Diabetic Retinopathy

Comparative efficacy of two different regimens of povidone-iodine 5% eye drops instillation in reducing conjunctival bacterial flora

ERG Findings after One Year Intravitreal Ranibizumab and Single or Multiple Spot Panphotocoagulation Treatment for Proliferative Diabetic Retinopathy

Reduced-Dose Indocyanine Green Photodynamic Therapy (iPDT) as an Optimized Treatment for Chronic Central Serous Chorioretinopathy

The Sympatholytic Non-selective β-blocker PROPRANOLOL as A Non-invasive Therapeutic Approach for the Treatment of Chronic Central Serous Chorioretinopathy (CSC)

Chromatic Full-field Stimulus Threshold (FST) in Proliferative Diabetic Retinopathy

Changes in Retinal Function and Structure Following Intravitreal Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Treatment for Diabetic Macular Edema

To View More...

You must be signed into an individual account to use this feature.